CLOV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Clover Health Investments Corp (CLOV) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has shown short-term price appreciation and bullish technical indicators, the lack of significant positive catalysts, speculative sentiment in the news, and limited financial data make it a less compelling choice for long-term investment. Holding off for more clarity or exploring more stable alternatives is recommended.
The technical indicators are bullish with the MACD histogram above 0 and positively contracting, RSI at 72.827 in the neutral zone, and SMA_5 > SMA_20 > SMA_200 indicating a bullish trend. The stock is trading near its resistance level of 5.057, with the next resistance at 5.38.
The stock has shown a 4.17% increase in regular market trading and a 0.40% post-market gain. Analysts have raised price targets recently, indicating some optimism.
News sentiment is speculative, with analysts favoring more stable alternatives like United Health and CVS. Hedge funds and insiders show neutral trading trends, and there is no recent congress trading data. Additionally, the stock has a 70% chance of declining 0.64% in the next day and 3.1% in the next month.
No financial data available for the latest quarter, making it difficult to assess growth trends or profitability.
Analysts have raised price targets recently (e.g., UBS from $2.75 to $4.75 and Canaccord from $3.20 to $4.20), but the overall sentiment remains cautious with a mix of Neutral and Buy ratings.
